Azelnidipine, a new calcium channel blocker, inhibits endothelial inflammatory response by reducing intracellular levels of reactive oxygen species.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Toshikazu Yoshikawa |
| Publication date | July 25, 2006 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |